InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.01%
)
US TECH 100
19,320.04
(
0.36%
)
Dow Jones
42,196.52
(
0.09%
)
Brent Oil
74.62
(
0.00%
)
Bitcoin
61,157.31
(
0.88%
)
Post# of 253268
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: genisi post# 71111

Thursday, 12/17/2009 1:34:41 PM

Thursday, December 17, 2009 1:34:41 PM

Post# of 253268
ANA598 - data at 4 weeks for the first dose cohort, 200 mg bid, in an ongoing Phase II study:

http://www.anadyspharma.com/pr_pdfs/ana598%204-week%20interim%20results%20final%2012.17.09.pdf

Still a difference between genotypes 1a and 1b but what looks strange here is that VL change was quite similar in genotype 1b and placebo 3.7 and 3.9 (log10 IU/ml) respectively.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up